Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Sanofi has asked the ...
Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. Lizzy Lawrence leads STAT’s coverage of the ...
Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.
According to CDC data, just over 13% of adults have reported using an anti-depressant. Last year, HHS released a report ...
Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change health care are reasonable, but also self ...
I have spent the last 10 years of my life investigating psychedelics as novel treatments for mental health conditions. When ...
His real name is Will Flanary, but you probably know him as Dr. Glaucomflecken — the internet’s go-to doctor/comedian. On ...
A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.
Karlawish is a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania’s ...
A high-profile study on AI's diagnostic capabilities, role of telehealth in abortion access, and an Epic lawsuit.
Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over ...
Three passengers are dead. Seven people are ill. The ship is anchored off Cape Verde, passengers cannot disembark, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results